World's Best Scientists 2026 revealed!
Charles H. Adler

Charles H. Adler

D-Index & Metrics

Medicine

D-Index
103
Citations
52369
World Ranking
7223
National Ranking
3789

Overview

Charles H. Adler is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on medical and neurological conditions, with a strong emphasis on Parkinson's disease and related neurological disorders.

The main fields of study for the scientist include Medicine, with a significant number of publications within the subfields of Neurology, Epidemiology, Radiology, Nuclear Medicine and Imaging, Physiology, and Cellular and Molecular Neuroscience. These areas reflect a broad engagement with both clinical and biological aspects of neurological diseases.

Key research topics Charles H. Adler has contributed to include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Traumatic Brain Injury Research
  • Botulinum Toxin and Related Neurological Disorders
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Genetic Neurodegenerative Diseases
  • Olfactory and Sensory Function Studies

Charles H. Adler has collaborated extensively with frequent co-authors such as Thomas G. Beach, Geidy E. Serrano, Holly A. Shill, Yorghos Tripodis, and Michael L. Alosco, indicating active participation within a network of researchers focused on neurological studies.

Their work has been published in several high-profile scientific venues, notably including:

  • Neurology
  • Alzheimer s & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Parkinsonism & Related Disorders
  • Movement Disorders

Some of the recent papers authored or co-authored by Charles H. Adler are:

  • "A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria," 2024, The Lancet Neurology
  • "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome," 2021, Neurology
  • "Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder," 2021, The Lancet Neurology
  • "Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines," 2020, UNC Libraries
  • "α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy," 2021, Acta Neuropathologica

Best Publications

  • MDS clinical diagnostic criteria for Parkinson's disease

    Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe

  • α-Synuclein Locus Triplication Causes Parkinson's Disease

    A. B. Singleton;M. Farrer;J. Johnson;A. Singleton

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • MDS research criteria for prodromal Parkinson's disease

    Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem

  • Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

    Jeffrey H. Kordower;C. Warren Olanow;Hemraj B. Dodiya;Yaping Chu

  • Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

    Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Linda Vedders

  • MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

    Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman

  • PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

    Bin Zheng;Zhixiang Liao;Joseph J. Locascio;Kristen A. Lesniak

  • Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction

    Thomas G. Beach;Charles H. Adler;LihFen F. Lue;Lucia I. Sue

  • A controlled trial of rasagiline in early Parkinson disease: The tempo study

    Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz

  • Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

    Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons

  • Defining mild cognitive impairment in Parkinson's disease.

    John Nathaniel Caviness;Erika M Driver-Dunckley;Donald J. Connor;Marwan N. Sabbagh

  • Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

    Charles H. Adler;Thomas G. Beach;Joseph G. Hentz;Holly A. Shill

  • Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

    Thomas G. Beach;Charles H. Adler;Lucia I. Sue;Geidy Serrano

  • Parkinsonism reduces coordination of fingers, wrist, and arm in fine motor control

    Hans Leo Teulings;José L. Contreras-Vidal;George E. Stelmach;Charles H. Adler

  • Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

    Alex E. Roher;Chera L. Esh;Tyler A. Kokjohn;Eduardo Miguel Castaño

  • Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

    B. F. Boeve;M. H. Silber;T. J. Ferman;S. C. Lin

  • The neurobiological basis of cognitive impairment in Parkinson's disease.

    Glenda M. Halliday;James B. Leverenz;Jay S. Schneider;Charles H. Adler

  • Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology

    Kasandra Burgos;Ivana Malenica;Raghu Metpally;Amanda Courtright

  • Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

    A. Brashear;M. F. Lew;D. D. Dykstra;C. L. Comella

Frequent Co-Authors

John N. Caviness
John N. Caviness Mayo Clinic
Holly A. Shill
Holly A. Shill Barrow Neurological Institute
Marwan N. Sabbagh
Marwan N. Sabbagh Lou Ruvo Brain Institute
Thomas G. Beach
Thomas G. Beach Banner Health
Douglas G. Walker
Douglas G. Walker Arizona State University
Joseph Jankovic
Joseph Jankovic Baylor College of Medicine
Robert A. Hauser
Robert A. Hauser University of South Florida
Kenneth Marek
Kenneth Marek Institute for Neurodegenerative Disorders
Irene Litvan
Irene Litvan University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA opens diverse pathways beyond the traditional MD route. Many students broaden their expertise or accelerate their healthcare careers by pursuing specialized online degrees. For those interested in healthcare leadership and administration, most affordable mha programs offer a flexible way to advance while managing costs.

Nursing professionals seeking to take on advanced clinical roles can benefit from MSN to DNP programs online, which prepare them for leadership in practice and research (msn to dnp programs online). Similarly, those interested in pharmacology can explore accredited online pharmacy programs to deepen their expertise or transition to clinical and research roles in pharmacy.

For students drawn to the management of medical records and health data, earning a degree through rhia certification programs online can open up growing positions in health information management. These online pathways make it possible to advance your skills, expand your options, and meet the demands of the evolving healthcare landscape—all from anywhere in the world.

Best Scientists Citing Charles H. Adler

Trending Scientists